Rochau, Ursula; Schwarzer, Ruth; Jahn, Beate; … - In: Applied Health Economics and Health Policy 12 (2014) 2, pp. 103-115
While several well-designed models of CML treatment strategies exist, there remains a need for the assessment of the long-term efficacy and cost effectiveness of novel treatment options such as second-generation TKIs. Additionally, these models should be validated using independent data. </AbstractSection>...